Ig λ chain V4A refers to a specific variable region of the lambda light chain of immunoglobulins (Ig), which are critical components of the adaptive immune system. Immunoglobulins, also known as antibodies, are glycoproteins produced by B cells (B lymphocytes) that recognize and bind to specific antigens, such as pathogens or foreign substances, to neutralize them or mark them for destruction by other immune cells.The structure of an antibody is composed of two heavy chains and two light chains, either kappa (κ) or lambda (λ), which are held together by disulfide bonds. Each light chain includes a variable (V) region and a constant (C) region. The variable region is responsible for antigen binding and is unique to each antibody, allowing for the vast diversity of antigen specificity necessary for the immune system to recognize a wide array of antigens.
The "V4A" designation indicates that this is the fourth variable region within the lambda light chains, subgroup A. This region is encoded by a specific V gene segment in the lambda light chain locus. During B cell development, V (variable), J (joining), and sometimes D (diversity) gene segments undergo a process called V(D)J recombination to create a unique V region sequence. This recombination is a key mechanism contributing to the diversity of the antibody repertoire.The Ig λ chain V4A contributes to the antigen-binding site of the antibody through its complementarity-determining regions (CDRs), which are hypervariable loops that directly interact with the antigen. The precise shape and charge distribution of the CDRs dictate the specificity and affinity of the antibody for its corresponding antigen. The lambda light chains, including the V4A variant, pair with heavy chains to form a complete immunoglobulin that can effectively target and neutralize specific antigens, playing a vital role in the body's immune defense.
関連項目
| 製品名 | CAS # | カタログ # | 数量 | 価格 | 引用文献 | レーティング |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
シクロスポリンAはカルシニューリンを阻害し、T細胞の活性化を減少させます。この免疫抑制効果は、適応免疫反応の一部としてIg λ 鎖 V-IV 領域 Len の産生増加を間接的に必要とする可能性があります。 | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMAはB細胞の活性化に関与するプロテインキナーゼCを活性化する。これはB細胞の分化を促進し、Ig λ鎖V-IV領域Lenの発現を増加させる可能性がある。 | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
LPSはToll様受容体4を介してB細胞の増殖と分化を刺激し、おそらく活性化B細胞によるIg λ鎖V-IV領域Lenの産生を促進する。 | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
イオノマイシンは細胞内カルシウム濃度を上昇させ、B細胞の活性化を刺激し、Igλ鎖V-IV領域レンの発現をアップレギュレートする可能性がある。 | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187はカルシウムイオノフォアとして作用し、細胞内カルシウムレベルを上昇させ、B細胞の活性化とそれに続くIgλ鎖V-IV領域レンの発現を誘発すると考えられる。 | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
レチノイン酸はB細胞のホメオスタシスに影響を与え、免疫グロブリンの発現を調節し、Igλ鎖V-IV領域Lenのレベルに影響を与える可能性がある。 | ||||||